Patient demographics and stroke data stratified by catheter
| All cases (n, %) | ACE68 (n, %) | Sofia Plus (n, %) | CAT6 (n, %) | 6F Navien (n, %) | P value | ||||||
| No of cases | 180 | 66 | 36.7 | 20 | 11.1 | 69 | 38.3 | 25 | 13.9 | ||
| Mean age (years) | 70.7 | 73.6 | 70.9 | 68.9 | 69.5 | 0.287* | |||||
| Female | 98 | 54.4 | 41 | 62.1 | 13 | 65.0 | 32 | 46.4 | 12 | 48.0 | 0.195† |
| Race | |||||||||||
| Caucasian | 150 | 83.3 | 55 | 83.3 | 16 | 80.0 | 58 | 84.1 | 21 | 84.0 | 0.549† |
| African-American | 13 | 7.2 | 4 | 6.1 | 2 | 10.0 | 7 | 10.1 | 0 | 0.0 | |
| Hispanic | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | |
| Asian | 2 | 1.1 | 1 | 1.5 | 0 | 0.0 | 1 | 1.4 | 0 | 0.0 | |
| Other/unspecified | 15 | 8.3 | 6 | 9.1 | 2 | 10.0 | 3 | 4.3 | 4 | 16.0 | |
| Comorbidities | |||||||||||
| Hypertension | 138 | 76.7 | 53 | 80.3 | 16 | 80.0 | 52 | 75.4 | 17 | 68.0 | 0.636† |
| History of TIA/stroke | 31 | 17.2 | 11 | 16.7 | 5 | 25.0 | 9 | 13.0 | 6 | 24.0 | 0.491† |
| Tobacco use | 45 | 25.0 | 19 | 28.8 | 2 | 10.0 | 18 | 26.1 | 6 | 24.0 | 0.404† |
| Atrial fibrillation | 73 | 40.6 | 23 | 34.8 | 13 | 65.0 | 25 | 36.2 | 12 | 48.0 | 0.073† |
| Diabetes mellitus | 42 | 23.3 | 14 | 21.2 | 6 | 30.0 | 19 | 27.5 | 3 | 12.0 | 0.378† |
| Coronary artery disease | 57 | 31.7 | 21 | 31.8 | 4 | 20.0 | 24 | 34.8 | 8 | 32.0 | 0.665† |
| Daily alcohol use | 8 | 4.4 | 1 | 1.5 | 2 | 10.0 | 4 | 5.8 | 1 | 4.0 | 0.344† |
| Hyperlipidemia | 95 | 52.8 | 31 | 47.0 | 13 | 65.0 | 38 | 55.1 | 13 | 52.0 | 0.525† |
| NIHSS, mean | 17.4 | 18.1 | 18.9 | 16.0 | 18.3 | 0.085* | |||||
| ASPECTs, mean | 8.8±1.2 | 8.9±1.0 | 8.8±1.1 | 8.9±1.0 | 8.3±1.8 | 0.129* | |||||
| tPA given | 67 | 37.2 | 26 | 39.4 | 5 | 25.0 | 27 | 39.1 | 9 | 36.0 | 0.688† |
| Clot location | |||||||||||
| ICA terminus | 56 | 31.1 | 26 | 39.4 | 7 | 35.0 | 11 | 15.9 | 12 | 48.0 | 0.004† 0.13† 0.09† |
| M1 | 113 | 62.8 | 39 | 59.1 | 12 | 60.0 | 50 | 72.5 | 12 | 48.0 | |
| Basilar | 11 | 6.1 | 1 | 1.5 | 1 | 5.0 | 8 | 11.6 | 1 | 4.0 | |
*ANOVA.
†Pearson χ2 test.